Any feedback?
Literature summary for 3.4.21.22 extracted from
- Antidote-controlled antithrombotic therapy targeting factor IXa and von Willebrand factor (2009), Ann. N. Y. Acad. Sci., 1175, 61-70.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | target of therapy in thrombotic disorders, application of a complementary oliconucleotide antidote to RB006, a aptamer-based inhibitor to factor IXa, return factor IX activity to its baseline levels | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| RB006 | - |
Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| factor IXa | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
